EU ACC3 PROGRAMME Could the EU ACC3 programme be of interest to you?

Is your company located in a country outside the European Union? Are you a manufacturer or producer of goods? Or Are you a freight forwarder, screening facility, ground handler or postal operator? Are those goods delivered to the European Union?

Are those goods delivered by aircraft? Did you tick all 4 boxes? In that case, the EU ACC3 programme could be of interest to you.

More information Further details on the EU ACC3 programme, the security requirements and EU aviation security validation can be found on the website of the European Commission http://ec.europa.eu/transp ort/modes/air/security/car go-mail/entities_en.htm

INFORMATION FOR SHIPPERS, FREIGHT FORWARDERS, SCREENING FACILITIES, GROUND HANDLERS AND POSTAL OPERATORS Since 1 February 2012, the EU has put in place the EU ACC3 programme. Under this programme, air carriers are required to ensure appropriate security measures for all cargo or mail they fly from a country outside the EU into the EU. As a shipper, freight forwarder, screening facility, ground handler or postal operator you may handle cargo or mail relevant to this programme.

Background Air carriers are required to protect the consignments they fly against terrorist acts. This can be done through physical screening (e.g. Xray) or by ensuring that consignments have been protected against unauthorized interference from the start of the supply chain. Since 1 February 2012, air carriers flying cargo or mail from outside the European Union (EU) into the EU are required to ensure that these security measures are in place for cargo and mail bound for the EU. Air carriers that fulfil these requirements are part of the EU ACC3 programme. As a shipper, freight forwarder, screening facility, ground handler or postal operator, you may form part of the supply chain of an air carrier. If you produce, transport, screen or otherwise handle goods that are delivered to the European Union by aircraft, the EU ACC3 programme might be relevant to you.

EU ACC3 programme If you become part of the EU ACC3 programme, you produce, transport, screen or otherwise handle goods under secure conditions.

As a result, these goods do not need to be (re)screened by the air carrier before they are flown to the EU, thereby facilitating the trade flow to the EU.

Requirements To become part of the EU ACC3 programme you need to fulfil certain security objectives and invite an approved EU aviation security validator to validate your cargo and mail operations. The list of approved auditors can be found on the website of the European Commission. The validation exercise includes an examination of your security programme and an on-site verification of the implementation of security measures. These security measures include access control to your premises, limiting access to air cargo and mail to authorized persons, security training for these persons, proper packaging, screening according to EU standards, etc. A successful validation grants you the status 'Third country known consignor' (KC3) or 'Third country regulated agent' (RA3), depending on your operations. With this status, you can engage with air carriers and become part of their secure supply chain.

Information provided by the European Commission – DG MOVE (February 2014)

EU ACC3 - European Commission - Europa EU

As a shipper, freight forwarder, screening facility, ground handler or postal operator you may handle cargo or mail relevant to this programme. Is your company.

56KB Sizes 3 Downloads 277 Views

Recommend Documents

The CETA Agreement - European Commission - Europa EU
Regarding wine and spirits CETA also: • abolishes the Canadian requirement to blend imported bulk spirits with local spirits before bottling – a requirement that made it impossible for EU makers of products classified as Geographical. Indications

EU Innovation Network - European Medicines Agency - Europa EU
New NCAs* from September 2016 to date. The Czech Republic – October 2016. Germany (BfArM) – October 2016. Denmark – November 2016. Norway ...

EU Innovation Network - European Medicines Agency - Europa EU
European Medicines Agency www.ema.europa.eu. EU Innovation Offices Network. E-mail addresses for users. Contact: [email protected].

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...